HEPATITIS C MONITORING PANEL Test
Test Cost: AED 2010.0
Symptoms, Diagnosis, and Test Components
The HEPATITIS C MONITORING PANEL test is a blood test that is used to monitor the progression and treatment of Hepatitis C infection. It measures various markers in the blood that can indicate the presence and severity of the infection, as well as the response to treatment. The test components include:
- HCV RNA Quantitative Real Time PCR
- CBC
- ALT (SGPT)
- AST (SGOT)
- Creatinine, serum
- Bilirubin, direct
- Bilirubin, total
- Urea, serum
Price: AED 2010.0
Sample Condition
3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube and 3 mL (2 mL min.) plasma from 2 Lavender Top (EDTA) tubes and 3 mL (2 mL min.) serum from 1 SST. Separate plasma within 2 hours of collection. Ship refrigerated. DO NOT FREEZE. 12 hours fasting is recommended. Hemolysed specimens are not acceptable.
Report Delivery
Sample Tue / Fri by 11 am; Report Thu / Mon
Method
DPD, Electrical Impedence, VCS, IFCC, Real Time PCR, Compensated Jaffe’s ReactionIDMS Traceable, Urease UV
Test Type
Disorders of Liver
Doctor
Gastroenterologist
Test Department
Pre Test Information: 12 hours fasting is recommended.
Test Details
The HEPATITIS C MONITORING PANEL test is a blood test that is used to monitor the progression and treatment of Hepatitis C infection. It measures various markers in the blood that can indicate the presence and severity of the infection, as well as the response to treatment. Some of the markers that may be included in the panel are:
- Hepatitis C virus (HCV) RNA: This measures the amount of the virus in the blood. A high viral load may indicate active infection.
- Liver enzymes: Elevated levels of liver enzymes such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) may indicate liver damage caused by the infection.
- Liver function tests: These tests measure the levels of various substances in the blood that are produced by the liver. Abnormal levels may indicate liver dysfunction.
- Hepatitis C antibody: This test detects the presence of antibodies produced by the immune system in response to Hepatitis C infection. A positive result indicates a current or past infection.
- Genotype testing: This determines the specific strain or genotype of the Hepatitis C virus. Different genotypes may respond differently to treatment.
- Fibrosis markers: These tests measure the degree of liver fibrosis or scarring. They can help determine the stage of liver disease and guide treatment decisions.
The HEPATITIS C MONITORING PANEL test is typically ordered by healthcare providers to assess the progression of the infection, monitor liver function, and evaluate the effectiveness of antiviral treatment. It is important for individuals with Hepatitis C to undergo regular monitoring to ensure timely intervention and management of the infection.
Test Name | HEPATITIS C MONITORING PANEL Test |
---|---|
Components | *HCV RNA Quantitative Real Time PCR*CBC *ALT (SGPT)*AST (SGOT)*Creatinine, serum*Bilirubin,direct*Bilirubin, total*Urea, serum |
Price | 2010.0 AED |
Sample Condition | 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tubeAND 3 mL (2 mL min.) plasma from 2 Lavender Top (EDTA) tubes AND 3 mL (2 mL min.) serum from 1 SST. Separate plasma within 2 hours of collection.Ship refrigerated. DO NOT FREEZE. 12 hours fasting is recommended. Hemolysed specimensarenotacceptable. |
Report Delivery | Sample Tue / Fri by 11 am; Report Thu / Mon |
Method | DPD, Electrical Impedence, VCS, IFCC, Real Time PCR , Compensated Jaffe’s ReactionIDMS Traceable, Urease UV |
Test type | Disorders of Liver |
Doctor | Gastroenterologist |
Test Department: | |
Pre Test Information | 12 hours fasting is recommended. |
Test Details |
The HEPATITIS C MONITORING PANEL test is a blood test that is used to monitor the progression and treatment of Hepatitis C infection. It measures various markers in the blood that can indicate the presence and severity of the infection, as well as the response to treatment. Some of the markers that may be included in the panel are: 1. Hepatitis C virus (HCV) RNA: This measures the amount of the virus in the blood. A high viral load may indicate active infection. 2. Liver enzymes: Elevated levels of liver enzymes such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) may indicate liver damage caused by the infection. 3. Liver function tests: These tests measure the levels of various substances in the blood that are produced by the liver. Abnormal levels may indicate liver dysfunction. 4. Hepatitis C antibody: This test detects the presence of antibodies produced by the immune system in response to Hepatitis C infection. A positive result indicates a current or past infection. 5. Genotype testing: This determines the specific strain or genotype of the Hepatitis C virus. Different genotypes may respond differently to treatment. 6. Fibrosis markers: These tests measure the degree of liver fibrosis or scarring. They can help determine the stage of liver disease and guide treatment decisions. The HEPATITIS C MONITORING PANEL test is typically ordered by healthcare providers to assess the progression of the infection, monitor liver function, and evaluate the effectiveness of antiviral treatment. It is important for individuals with Hepatitis C to undergo regular monitoring to ensure timely intervention and management of the infection. |